A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain

Shawn C Chafe1,2, Kui Zhai1,2,3, Nikoo Aghaei4

  • 1Department of Surgery, McMaster University, Hamilton, ON L8S 4L8, Canada.

PubMed

Insights

Activating beta-secretase 1 (BACE1), linked to Alzheimer's disease, significantly increased brain metastases in non-small cell lung cancer (NSCLC). Inhibiting BACE1 blocked this spread, revealing a potential therapeutic target.

Area of Science:

  • Oncology
  • Neuroscience
  • Genetics

Background:

  • Brain metastasis is a frequent complication in non-small cell lung cancer (NSCLC), affecting up to 40% of patients.
  • Significant genomic differences exist between primary lung tumors and their brain metastases, with key drivers often unknown.

Purpose of the Study:

  • To identify molecular drivers of brain metastasis in non-small cell lung cancer (NSCLC).
  • To explore the role of beta-secretase 1 (BACE1) in promoting NSCLC brain metastasis.
  • To investigate BACE1 as a potential therapeutic target for NSCLC brain metastasis.

Main Methods:

  • Utilized an in vivo genome-wide CRISPR activation screen in an orthotopic xenograft model derived from an NSCLC patient.
  • Assessed the impact of gene activation on the development of brain metastases.
  • Investigated the effects of genetic and pharmacological inhibition of BACE1 on NSCLC brain metastasis.
  • Elucidated the downstream signaling pathway involving epidermal growth factor receptor (EGFR).

Main Results:

  • Activation of beta-secretase 1 (BACE1) substantially increased the incidence of brain metastases in the NSCLC model.
  • Genetic and pharmacological inhibition of BACE1 effectively blocked NSCLC brain metastasis.
  • BACE1 was found to mediate its pro-metastatic effects through the epidermal growth factor receptor (EGFR) pathway.

Conclusions:

  • In vivo CRISPR activation screening is a powerful tool for discovering metastasis drivers.
  • Beta-secretase 1 (BACE1) is a key molecular driver of non-small cell lung cancer (NSCLC) brain metastasis.
  • Targeting BACE1, potentially in combination with EGFR pathways, offers a promising therapeutic strategy for NSCLC brain metastasis.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...